The U.S. Supreme Court has indicated that a stock fraud lawsuit can move forward against the makers of the cold remedy Zicam, whom investors say misrepresented their company’s growth potential…
A Zicam class action lawsuit has made its way to the U.S. Supreme Court, where the justices will try to determine how much information companies are obligated to share with…
The makers of Zicam have indicated that they are offering a $15.5 million to settle lawsuits brought by consumers who allege that they lost their sense of taste and smell…
A $429,000 settlement has been reached between the makers of Zicam allergy and cold medicines and several California counties over allegations that the company was attempting to mislead consumers with…
A settlement has been reached by Matrixx Initiatives to resolve Zicam lawsuits filed by a group of plaintiffs who alleged that the company misrepresented the safety of their nasal sprays…
A University of California researcher says that the findings of a new study provide proof that zinc-based Zicam nasal products, which were recalled last year, may cause some people to…
The FDA is refusing to reverse a warning about loss of smell from Zicam, which led to a recall last summer for the over-the-counter cold remedy’s nasal sprays and gels.
Matrixx Initiatives has renewed a request that the FDA reverse a warning to consumers that side effects of Zicam nasal sprays and gels can cause loss of smell, and are…
According to Matrixx Initiatives, Inc., maker of Zicam cold remedy, the FDA is not going to reverse a prior stance that prevents the company from marketing the over-the-counter homeopathic remedy…
Following a Zicam recall issued earlier this year for nasal gel and nasal swab versions of the popular cold remedy due to a potential risk that they may cause users…
